Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AC009336.19 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
mRNA | MXRA8 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
mRNA | SNX11 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
mRNA | SLC39A11 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
mRNA | MICA | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
mRNA | C1QTNF3 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
mRNA | DZIP1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | BLNK | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
mRNA | ANP32B | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
mRNA | LDB1 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |